MIH
XPH icon

Meitav Investment House’s State Street SPDR S&P Pharmaceuticals ETF XPH Stock Holding History

Meitav Investment House’s Portfolio XPH Stock Details XPH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-4,607
Closed -$209K – 460
2019
Q4 		$209K Buy
+4,607
New +$183K 0.02% 395
2019
Q2 		– Sell
-6,807
Closed -$283K – 492
2019
Q1 		$283K Sell
6,807
-3,193
-32% -$130K 0.02% 327
2018
Q4 		$364K Sell
10,000
-40,107
-80% -$1.71M 0.02% 234
2018
Q3 		$2.43M Buy
50,107
+5,107
+11% +$242K 0.12% 109
2018
Q2 		$1.93M Buy
45,000
+17,175
+62% +$721K 0.09% 123
2018
Q1 		$1.16M Buy
+27,825
New +$1.21M 0.06% 145

Other funds holding XPH

Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $761B AUM 31.28% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.47T AUM 27.86% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
WBG
Wharton Business Group Malvern, Pennsylvania $2.65B AUM 20.73% 1-Year Est. Return
FMP
Financial Management Professionals Austin, Texas $1.05B AUM 21.07% 1-Year Est. Return
BCM
Brookstone Capital Management Wheaton, Illinois $9.96B AUM 23.61% 1-Year Est. Return
HCIA
Hochman Cole Investment Advisors Deerfield, Illinois $255M AUM 23.27% 1-Year Est. Return
FCBT
First Citizens Bank & Trust Raleigh, North Carolina $6.69B AUM 24.48% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $376B AUM 19.32% 1-Year Est. Return